Pharm Tech Minutes 2010.12.20: Difference between revisions
Jump to navigation
Jump to search
| Line 32: | Line 32: | ||
This also a requirement : so we use it. | This also a requirement : so we use it. | ||
We ackowledge that CDA is NOT intended to manage the workflow, which will be managed using XDW profile. | |||
We ackowledge that CDA is NOT intended to manage the workflow, | |||
which will be managed using XDW profile. | |||
===on Common part (second part)=== | ===on Common part (second part)=== | ||
* NeHTA Australia | * NeHTA Australia | ||
Revision as of 15:29, 20 December 2010
Participant list
- Jürgen Brandstätter, CodeWerk, Austria
- Jose Costa Teixeira, Agfa Healthcare
- Marc Robberecht, Agfa Healthcare
- Simon Letellier, EAHP, France
- Viktor Hafner, Austria
- Stephen Chu, NeHTA, Australia
Comments processed
GoTo Meeting TCon Dec 20., 2010, 21:00 – 23:00 (UTC+1)
on CMPD
- Siemens
IHE Pharmacy group can't wait 2 years for the release of CDAv3.
Important characteristics of CDAv2 are :
- persistance of information
- authentication
This also a requirement : so we use it.
We ackowledge that CDA is NOT intended to manage the workflow,
which will be managed using XDW profile.
on Common part (second part)
- NeHTA Australia